Trinity Biotech Plc (TRIB)
0.7121
-0.03
(-4.20%)
USD |
NASDAQ |
Feb 20, 16:00
0.7051
-0.01
(-0.98%)
After-Hours: 20:00
Trinity Biotech SG&A Expense (Quarterly) : 6.429M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amarin Corp. Plc | 17.83M |
| DBV Technologies SA | 8.399M |
| Ascendis Pharma A/S | 158.13M |
| Cellectis SA | 5.184M |
| Akari Therapeutics Plc | 1.963M |